Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/14344
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Classification of the kinetics of factor VIII inhibitors in haemophilia A: plasma dilution studies are more discriminatory than time-course studies
Author: Ling, M.
Duncan, E.
Rodgers, S.
Somogyi, A.
Crabb, G.
Street, A.
Lloyd, J.
Citation: British Journal of Haematology, 2001; 114(4):861-867
Publisher: Blackwell Science Ltd
Issue Date: 2001
ISSN: 0007-1048
1365-2141
Statement of
Responsibility: 
M. Ling, E. M. Duncan, S. E. Rodgers, A. A. Somogyi, G. A. Crabb, A. M. Street and J. V. Lloyd
Abstract: Factor VIII inhibitors have previously been classified as type I or type II using complex experiments that study the time course of inactivation of factor VIII and the effect of varying the antibody concentration. Classification may be important to better understand inhibitor behaviour in vivo. To determine the most reliable method of classifying the kinetics of factor VIII inactivation, we studied 11 patients with haemophilia A, comprising five severe, three mild and three acquired cases, and compared the classification obtained from plasma dilution studies and time‐course studies. The plasma dilution studies showed two distinctly different patterns: a steep slope with complete FVIII:C inactivation at high antibody concentrations for type I inhibitors and a FVIII:C plateau with incomplete inactivation for type II inhibitors. Six type I (four severe, one mild and one acquired) and two type II (one mild and one acquired) inhibitors were classified using either plasma samples or purified and concentrated IgG, while the remaining were undetermined owing to insufficient available plasma. In contrast, the time‐course studies could not discriminate between these groups. We recommend that plasma dilution studies be used for the classification of in vitro kinetics of factor VIII inhibitors.
Keywords: Haemophilia A; factor VIII; inhibitors; kinetics; mutation
Description: The definitive version is available at www.blackwell-synergy.com
RMID: 0020010764
DOI: 10.1046/j.1365-2141.2001.03067.x
Published version: http://www.blackwell-synergy.com/doi/abs/10.1046/j.1365-2141.2001.03067.x
Appears in Collections:Pharmacology publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.